302 related articles for article (PubMed ID: 24122876)
1. ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation.
Qie S; Chu C; Li W; Wang C; Sang N
J Cell Biochem; 2014 Mar; 115(3):498-509. PubMed ID: 24122876
[TBL] [Abstract][Full Text] [Related]
2. Phosphoinositide 3-kinase targeting by the beta galactoside binding protein cytokine negates akt gene expression and leads aggressive breast cancer cells to apoptotic death.
Wells V; Mallucci L
Breast Cancer Res; 2009; 11(1):R2. PubMed ID: 19133120
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-8 upregulates integrin β3 expression and promotes estrogen receptor-negative breast cancer cell invasion by activating the PI3K/Akt/NF-κB pathway.
Shao N; Lu Z; Zhang Y; Wang M; Li W; Hu Z; Wang S; Lin Y
Cancer Lett; 2015 Aug; 364(2):165-72. PubMed ID: 25979232
[TBL] [Abstract][Full Text] [Related]
4. Heat Shock Factor 1 Epigenetically Stimulates Glutaminase-1-Dependent mTOR Activation to Promote Colorectal Carcinogenesis.
Li J; Song P; Jiang T; Dai D; Wang H; Sun J; Zhu L; Xu W; Feng L; Shin VY; Morrison H; Wang X; Jin H
Mol Ther; 2018 Jul; 26(7):1828-1839. PubMed ID: 29730197
[TBL] [Abstract][Full Text] [Related]
5. A Rac-Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells.
Arias-Romero LE; Villamar-Cruz O; Pacheco A; Kosoff R; Huang M; Muthuswamy SK; Chernoff J
Oncogene; 2010 Oct; 29(43):5839-49. PubMed ID: 20711231
[TBL] [Abstract][Full Text] [Related]
6. GLS1 promotes proliferation in hepatocellular carcinoma cells via AKT/GSK3β/CyclinD1 pathway.
Xi J; Sun Y; Zhang M; Fa Z; Wan Y; Min Z; Xu H; Xu C; Tang J
Exp Cell Res; 2019 Aug; 381(1):1-9. PubMed ID: 31054856
[TBL] [Abstract][Full Text] [Related]
7. Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
Lyu H; Huang J; Edgerton SM; Thor AD; He Z; Liu B
Int J Clin Exp Pathol; 2015; 8(6):6143-56. PubMed ID: 26261492
[TBL] [Abstract][Full Text] [Related]
8. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
[TBL] [Abstract][Full Text] [Related]
9. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
Mukha A; Kahya U; Linge A; Chen O; Löck S; Lukiyanchuk V; Richter S; Alves TC; Peitzsch M; Telychko V; Skvortsov S; Negro G; Aschenbrenner B; Skvortsova II; Mirtschink P; Lohaus F; Hölscher T; Neubauer H; Rivandi M; Labitzky V; Lange T; Franken A; Behrens B; Stoecklein NH; Toma M; Sommer U; Zschaeck S; Rehm M; Eisenhofer G; Schwager C; Abdollahi A; Groeben C; Kunz-Schughart LA; Baretton GB; Baumann M; Krause M; Peitzsch C; Dubrovska A
Theranostics; 2021; 11(16):7844-7868. PubMed ID: 34335968
[TBL] [Abstract][Full Text] [Related]
10. Glutaminase (GLS1) gene expression in primary breast cancer.
Vidula N; Yau C; Rugo HS
Breast Cancer; 2023 Nov; 30(6):1079-1084. PubMed ID: 37679553
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis.
Hao NB; Tang B; Wang GZ; Xie R; Hu CJ; Wang SM; Wu YY; Liu E; Xie X; Yang SM
Cancer Lett; 2015 May; 361(1):57-66. PubMed ID: 25727320
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of breast cancer resistance protein plays a role in HER2-mediated chemoresistance through PI3K/Akt and nuclear factor-kappa B signaling pathways in MCF7 breast cancer cells.
Zhang W; Ding W; Chen Y; Feng M; Ouyang Y; Yu Y; He Z
Acta Biochim Biophys Sin (Shanghai); 2011 Aug; 43(8):647-53. PubMed ID: 21712253
[TBL] [Abstract][Full Text] [Related]
13. Activation of p53 by costunolide blocks glutaminolysis and inhibits proliferation in human colorectal cancer cells.
Hu M; Liu L; Yao W
Gene; 2018 Dec; 678():261-269. PubMed ID: 30103008
[TBL] [Abstract][Full Text] [Related]
14. Chronic morphine treatment attenuates cell growth of human BT474 breast cancer cells by rearrangement of the ErbB signalling network.
Weingaertner IR; Koutnik S; Ammer H
PLoS One; 2013; 8(1):e53510. PubMed ID: 23308242
[TBL] [Abstract][Full Text] [Related]
15. CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-κB signaling pathway.
Shen T; Yang Z; Cheng X; Xiao Y; Yu K; Cai X; Xia C; Li Y
Oncol Rep; 2017 Apr; 37(4):2095-2100. PubMed ID: 28259918
[TBL] [Abstract][Full Text] [Related]
16. ErbB2, FoxM1 and 14-3-3ζ prime breast cancer cells for invasion in response to ionizing radiation.
Kambach DM; Sodi VL; Lelkes PI; Azizkhan-Clifford J; Reginato MJ
Oncogene; 2014 Jan; 33(5):589-98. PubMed ID: 23318431
[TBL] [Abstract][Full Text] [Related]
17. α-Tocopheryl succinate induces apoptosis in erbB2-expressing breast cancer cell via NF-κB pathway.
WANG XF; XIE Y; WANG HG; ZHANG Y; DUAN XC; LU ZJ
Acta Pharmacol Sin; 2010 Dec; 31(12):1604-10. PubMed ID: 21127496
[TBL] [Abstract][Full Text] [Related]
18. Glutaminase-1 stimulates the proliferation, migration, and survival of human endothelial cells.
Peyton KJ; Liu XM; Yu Y; Yates B; Behnammanesh G; Durante W
Biochem Pharmacol; 2018 Oct; 156():204-214. PubMed ID: 30144404
[TBL] [Abstract][Full Text] [Related]
19. Combinatorial targeting of FGF and ErbB receptors blocks growth and metastatic spread of breast cancer models.
Issa A; Gill JW; Heideman MR; Sahin O; Wiemann S; Dey JH; Hynes NE
Breast Cancer Res; 2013 Jan; 15(1):R8. PubMed ID: 23343422
[TBL] [Abstract][Full Text] [Related]
20. Silencing of glutaminase 1 resensitizes Taxol-resistant breast cancer cells to Taxol.
Fu A; Yu Z; Song Y; Zhang E
Mol Med Rep; 2015 Jun; 11(6):4727-33. PubMed ID: 25625774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
